Effects of PMCA2 mutation on DPOAE amplitudes and latencies in deafwaddler mice

D Konrad-Martin1, S J Norton, K E Mascher

  • 1Department of Speech and Hearing Sciences, University of Washington, Seattle 98195, USA. konradd@boystown.org

Hearing Research
|December 22, 2000
PubMed

Insights

The deafwaddler mouse mutation impacts outer hair cell function, affecting distortion product otoacoustic emissions (DPOAEs) and hearing, particularly at high frequencies. This highlights the role of PMCA2 in auditory health.

Area of Science:

  • Auditory Neuroscience
  • Genetics
  • Otoacoustic Emissions

Background:

  • The deafwaddler (dfw) mouse mutant has a mutation in the PMCA2 gene, crucial for plasma membrane calcium ATPase activity.
  • PMCA2 is expressed in cochlear and vestibular hair cells, suggesting a role in auditory function.

Purpose of the Study:

  • To investigate the impact of the dfw mutation on distortion product otoacoustic emissions (DPOAEs).
  • To compare DPOAEs in dfw mutants with those in control mice and furosemide-treated mice.

Main Methods:

  • DPOAE amplitude and phase were measured in control, dfw mutant, and furosemide-treated mice.
  • Data were analyzed using inverse fast Fourier transform to estimate DPOAE group delay.
  • DPOAEs were assessed as a function of the f(2)/f(1) ratio.

Main Results:

  • Homozygous dfw mutants showed no DPOAEs.
  • Heterozygous dfw mice (+/dfw) exhibited elevated DPOAE thresholds and reduced high-frequency amplitudes.
  • The dfw mutation affected DPOAEs differently than furosemide, particularly at high stimulus levels.

Conclusions:

  • The dfw mutation impairs outer hair cell (OHC) function, especially at high frequencies.
  • PMCA2 is essential for normal OHC function and high-frequency hearing.
  • The dfw mutation's effects on DPOAEs provide insights into auditory system disorders.

Related Concept Videos